Cover Image

The future of radioligand therapy: α, β, or both?

Saved in:
Bibliographic Details
Main Authors: Haberkorn, Uwe (Author) , Giesel, Frederik L. (Author) , Kratochwil, Clemens (Author)
Format: Article (Journal)
Language:English
Published: April 13, 2017
In: Journal of nuclear medicine
Year: 2017, Volume: 58, Issue: 7, Pages: 1017-1018
ISSN:2159-662X
DOI:10.2967/jnumed.117.190124
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.2967/jnumed.117.190124
Verlag, kostenfrei, Volltext: http://jnm.snmjournals.org/content/58/7/1017
Get full text
Author Notes:Uwe Haberkorn, Frederik Giesel, Alfred Morgenstern, Clemens Kratochwil

MARC

LEADER 00000caa a2200000 c 4500
001 1580664377
003 DE-627
005 20230427065709.0
007 cr uuu---uuuuu
008 180904s2017 xx |||||o 00| ||eng c
024 7 |a 10.2967/jnumed.117.190124  |2 doi 
035 |a (DE-627)1580664377 
035 |a (DE-576)510664377 
035 |a (DE-599)BSZ510664377 
035 |a (OCoLC)1341018074 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
245 1 4 |a The future of radioligand therapy  |b α, β, or both?  |c Uwe Haberkorn, Frederik Giesel, Alfred Morgenstern, Clemens Kratochwil 
246 3 0 |a alpha beta 
264 1 |c April 13, 2017 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.09.2018 
700 1 |a Giesel, Frederik L.  |d 1970-  |e VerfasserIn  |0 (DE-588)129031240  |0 (DE-627)387883878  |0 (DE-576)297457071  |4 aut 
700 1 |a Kratochwil, Clemens  |d 1978-  |e VerfasserIn  |0 (DE-588)134026276  |0 (DE-627)559871686  |0 (DE-576)300262787  |4 aut 
773 0 8 |i Enthalten in  |t Journal of nuclear medicine  |d New York, NY : Soc., 1964  |g 58(2017), 7, Seite 1017-1018  |h Online-Ressource  |w (DE-627)325793603  |w (DE-600)2040222-3  |w (DE-576)09475277X  |x 2159-662X  |7 nnas  |a The future of radioligand therapy α, β, or both? 
773 1 8 |g volume:58  |g year:2017  |g number:7  |g pages:1017-1018  |g extent:2  |a The future of radioligand therapy α, β, or both? 
856 4 0 |u http://dx.doi.org/10.2967/jnumed.117.190124  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jnm.snmjournals.org/content/58/7/1017  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180904 
993 |a Article 
994 |a 2017 
998 |g 134026276  |a Kratochwil, Clemens  |m 134026276:Kratochwil, Clemens  |d 910000  |d 911400  |e 910000PK134026276  |e 911400PK134026276  |k 0/910000/  |k 1/910000/911400/  |p 4  |y j 
998 |g 129031240  |a Giesel, Frederik L.  |m 129031240:Giesel, Frederik L.  |d 910000  |d 911400  |e 910000PG129031240  |e 911400PG129031240  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1580664377  |e 3024706496 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"The future of radioligand therapy","subtitle":"α, β, or both?","title_sort":"future of radioligand therapy"}],"language":["eng"],"person":[{"role":"aut","family":"Haberkorn","display":"Haberkorn, Uwe","given":"Uwe"},{"role":"aut","family":"Giesel","display":"Giesel, Frederik L.","given":"Frederik L."},{"display":"Kratochwil, Clemens","given":"Clemens","family":"Kratochwil","role":"aut"}],"name":{"displayForm":["Uwe Haberkorn, Frederik Giesel, Alfred Morgenstern, Clemens Kratochwil"]},"origin":[{"dateIssuedDisp":"April 13, 2017","dateIssuedKey":"2017"}],"recId":"1580664377","note":["Gesehen am 04.09.2018"],"relHost":[{"part":{"volume":"58","text":"58(2017), 7, Seite 1017-1018","pages":"1017-1018","year":"2017","issue":"7","extent":"2"},"id":{"eki":["325793603"],"issn":["2159-662X","1535-5667"],"zdb":["2040222-3"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 13.12.2021"],"corporate":[{"role":"isb","display":"Society of Nuclear Medicine"}],"origin":[{"dateIssuedDisp":"1964-","publisher":"Soc.","publisherPlace":"New York, NY","dateIssuedKey":"1964"}],"name":{"displayForm":["Society of Nuclear Medicine"]},"title":[{"title":"Journal of nuclear medicine","title_sort":"Journal of nuclear medicine","subtitle":"JNM"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["Nachgewiesen 5.1964 -"],"recId":"325793603","disp":"The future of radioligand therapy α, β, or both?Journal of nuclear medicine","titleAlt":[{"title":"JNM"}],"language":["eng"]}],"physDesc":[{"extent":"2 S."}],"id":{"eki":["1580664377"],"doi":["10.2967/jnumed.117.190124"]},"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a HABERKORNUFUTUREOFRA1320 

Similar Items